Component: (Network and Table)
Network
00100 - Statement - CONSOLIDATED BALANCE SHEETS
(http://www.collegiumpharma.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001267565 (http://www.sec.gov/CIK)
CONSOLIDATED BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
CONSOLIDATED BALANCE SHEETS
 
 
Assets
 
 
Current assets:
 
 
Cash and cash equivalents
153,225,000  
95,697,000  
Accounts receivable, net
2,129,000  
 
Inventory
1,316,000  
 
Prepaid expenses and other current assets
1,905,000  
1,186,000  
Total current assets
158,575,000  
 
96,883,000  
 
Property and equipment, net
1,038,000  
738,000  
Intangible assets, net
2,103,000  
 
Restricted cash
97,000  
97,000  
Other long-term assets
204,000  
 
Total assets
162,017,000  
 
97,718,000  
 
Liabilities and shareholders' equity (deficit)
 
 
Current liabilities:
 
 
Accounts payable
9,106,000  
3,537,000  
Accrued expenses
8,879,000  
2,228,000  
Deferred revenue
4,944,000  
 
Current portion of term loan payable
2,667,000  
2,667,000  
Total current liabilities
25,596,000  
 
8,432,000  
 
Lease incentive obligation
34,000  
68,000  
Term loan payable, long-term
1,479,000  
4,146,000  
Total liabilities
27,109,000  
 
12,646,000  
 
Commitments and contingencies (see Note 9)
xsi:nil  
xsi:nil  
Shareholders’ equity (deficit):
 
 
Preferred stock, $0.001 par value; authorized shares - 5,000,000 at December 31, 2016 and December 31, 2015; issued and outstanding shares - none at December 31, 2016 and December 31, 2015
xsi:nil  
xsi:nil  
Common stock, $0.001 par value; authorized shares - 100,000,000 at December 31, 2016 and December 31, 2015; issued and outstanding shares - 29,364,100 at December 31, 2016 and 20,739,351 at December 31, 2015
29,000  
21,000  
Additional paid-in capital
358,063,000  
214,062,000  
Accumulated deficit
(223,184,000) 
(129,008,000) 
Treasury stock
 
(3,000) 
Total shareholders’ equity
134,908,000  
 
85,072,000  
 
Total liabilities and shareholders’ equity
162,017,000  
 
97,718,000